About us

 

Who we are

Our mission is simple: support our people, collaborate with our partners, do it all for our patients - and continue Inventing for Life.

At MSD in the UK, we're 'Inventing for Life'. We're helping to transform the lives of millions of patients in the UK by providing innovative medicines, vaccines and services, through our partnerships with the NHS and the work of the inspiring people who make up our company.

 

2017

MSD announced plans to open a new state of the art discovery research centre and headquarters in London.

Scientific invention is at the heart of what we do

Our scientists were among the first to develop medicines to treat hypertension, HIV and Hepatitis C. Today we're conducting approximately 100 clinical studies in the UK with over 3,000 patients participating each year.

We are at the forefront of some of the world's most urgent global population and animal health challenges, including:

Oncology
Diabetes
Vaccines
Infectious
diseases
Cardiovascular
disease
Women’s
health

Oncology

MSD is inventing new ways to treat cancer with more than 450 clinical studies underway globally. Our immuno-oncology research is one of the fastest growing in the industry.

Diabetes

Our work in assisting the UK’s 3.2 million diagnosed diabetes sufferers goes beyond medicine, to address the lifestyle challenges associated with the condition, and working with professional and patient groups to increase awareness and improve the likelihood of diagnosis.

Vaccines

Over the past century, MSD has invented more than 40 vaccines to protect children, adolescents, adults and animals from serious diseases.

Infectious diseases

As the world continues to see a rise in infections which are resistant to antibiotic treatment, we are firmly committed to antimicrobial research. In 2016, we provided £250,000 of funding towards the UK Longitude Prize to help support innovators competing to find a test that helps rule out unnecessary use of antibiotics – a pressing problem of this century.

Cardiovascular disease

Our commitment to cardiovascular care began with one of the first oral antihypertensive medications in the 1950s and continued with research leading to new cholesterol-lowering statins in the 1970s. Today, we strive to meet even greater expectations by offering options for patients and healthcare providers. These include treatments and tools for healthcare professionals to highlight where treatment targets are not being met and suggesting where care can be improved.

Women’s health

We believe that raising awareness of healthcare options can be as vital as treatment provision itself, which is why we’re committed to ensuring that every woman in the UK has awareness of and access to the right contraceptive choices for her.

Oncology
Diabetes
Vaccines
Infectious
diseases
Cardiovascular
disease
Women’s
health

Oncology

MSD is inventing new ways to treat cancer with more than 450 clinical studies underway globally. Our immuno-oncology research is one of the fastest growing in the industry.

Diabetes

Our work in assisting the UK’s 3.2 million diagnosed diabetes sufferers goes beyond medicine, to address the lifestyle challenges associated with the condition, and working with professional and patient groups to increase awareness and improve the likelihood of diagnosis.

Vaccines

Over the past century, MSD has invented more than 40 vaccines to protect children, adolescents, adults and animals from serious diseases.

Infectious diseases

As the world continues to see a rise in infections which are resistant to antibiotic treatment, we are firmly committed to antimicrobial research. In 2016, we provided £250,000 of funding towards the UK Longitude Prize to help support innovators competing to find a test that helps rule out unnecessary use of antibiotics – a pressing problem of this century.

Cardiovascular disease

Our commitment to cardiovascular care began with one of the first oral antihypertensive medications in the 1950s and continued with research leading to new cholesterol-lowering statins in the 1970s. Today, we strive to meet even greater expectations by offering options for patients and healthcare providers. These include treatments and tools for healthcare professionals to highlight where treatment targets are not being met and suggesting where care can be improved.

Women’s health

We believe that raising awareness of healthcare options can be as vital as treatment provision itself, which is why we’re committed to ensuring that every woman in the UK has awareness of and access to the right contraceptive choices for her.

We're also committed to addressing health issues such as Alzheimer's disease.

For more than 10 years, MSD scientists have been researching different ways to treat Alzheimer's, which is one of the most daunting scientific and medical challenges of our time. This commitment continues today and, despite the odds, we're committed to sharing our learnings with others.

 
 

Our People

Our people are at the heart of everything we do
 

Our workforce is multigenerational with employees ranging in age from 19-70. We truly represent the diverse population that we serve and are proud to have employees who have been with us for 10, 20 and even more than 30 years.

 

We're committed to diversity and inclusion, with 38 per cent of senior roles across the UK at present filled by women (45 per cent in our Human Health Division) and two thirds of our UK Human Health senior leadership team are women.

 

We help our people become the very best in their fields and invest in their professional development whilst also encouraging a healthy work/life balance.

That’s why we have a range of programmes in place to support physical and mental wellbeing, including our ‘Live It’ programme providing support and resources for employees.

Our people are passionate about making a difference – and our success is built upon their motivation and their passion to save and improve lives.

 

Our Partnerships

MSD believes in the power of partnerships.

We aspire to make a difference, but we know that we can’t do it alone. No single organisation has everything it takes to deliver complete healthcare.

MSD
Spire
Hospify

£40 million on research

We’re proud to work with the NHS, leading universities, and other cutting-edge research bodies, as well as commercial and non-profit organisations across human health, animal health and manufacturing.

We understand we all have a role to play in transforming healthcare and that’s why, every year, we spend in the region of £40 million on research with the NHS and UK academic centres.

 

Primary care data

For example, in Scotland, MSD is supporting the Scottish Primary Care Information Resource – SPIRE – by enabling better use of primary care patient data for insight into the health needs of the country’s patient population.

 

investing in innovation

We have also supported a number of digital start-ups - including Hospify, a secure messaging app currently being trialled in NHS pilots.

 
 

Our Patients

We transform the lives of patients.

We are constantly pushing the boundaries of medical science, inventing medicines and vaccines to prevent and treat the world’s most challenging diseases.

 

One of our cancer medicines was the first of its type to receive a positive recommendation from NICE and was immediately made available through the Cancer Drugs Fund brining this medicine to NHS patients as quickly as possible.

 

In 2017 we reached over 2 million people in the UK through our vaccines.

 

Our scientists were among the first to develop medicines to treat hypertension, HIV and Hepatitis C, amongst others and we are committed to studying Alzheimer’s disease and addressing health issues such as antimicrobial resistance.

 

MSD is a member of the Hepatitis C coalition – a group of leading clinicians, patient organisations and other partners working to reduce the illness and death linked to Hepatitis C infection in the UK and we are working with the London Joint Working Group on Substance Use and Hepatitis C to address impact of Hepatitis C on people who inject drugs.

 

MSD’s plans for a new discovery research centre and head office in London will support the UK’s position as a world leader in developing science.

At MSD we are also committed to the communities around us

40 hours of paid volunteering

We encourage our employees to help others by giving them 40 hours paid volunteering each year. Some of our projects include Dementia Friends, Rennie Grove Hospice, the Scouts and Fareshare Foodbank. In one year, our employees donated over 3,000 hours to voluntary activities within local communities.

 

MSD Fellowship for global health

And it’s not just UK communities that we support. The MSD Fellowship for Global Health is a three-month, field-based pro bono programme designed to share the skills and talents of our employees worldwide. In July 2018, 29 MSD employees from around the world left their regular posts to work with partners in sub-Saharan Africa, Central Asia, India and the U.S. to help improve global health.

Since 1987 we’ve also been committed to donate as much medicine as needed to help eliminate River Blindness in affected areas in Africa, Latin America and Yemen.

As a result, both Colombia and Ecuador have received verification from the WHO that this goal has been achieved.

We’re actively involved in the fight against Ebola, contributing to the global response to major outbreaks, whilst our contribution to programmes to reduce HIV transmission in Africa means people no longer expect to die from AIDs.

 

MSD for Mothers

We also run our MSD for Mothers initiative - a 10-year $500 million programme - focused on improving the health and wellbeing of mothers during pregnancy and childbirth. This effort has so far provided more than six million women with improved access to affordable, quality care. Closer to home we support groups like Baby LifeLine in the North of England to run training courses that help pregnant women and unborn babies.

Job code: GB-NON-00464Date of preparation: May 2019